Absci Corp (ABSI)
4.62
-0.12
(-2.53%)
USD |
NASDAQ |
May 17, 16:00
4.62
0.00 (0.00%)
After-Hours: 20:00
Absci Total Liabilities (Quarterly): 34.79M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 34.79M |
| December 31, 2023 | 41.12M |
| September 30, 2023 | 39.93M |
| June 30, 2023 | 38.75M |
| March 31, 2023 | 41.84M |
| December 31, 2022 | 46.59M |
| September 30, 2022 | 46.44M |
| Date | Value |
|---|---|
| June 30, 2022 | 50.12M |
| March 31, 2022 | 54.96M |
| December 31, 2021 | 60.09M |
| September 30, 2021 | 61.11M |
| June 30, 2021 | 219.96M |
| March 31, 2021 | 321.34M |
| December 31, 2020 | 178.00M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
34.79M
Minimum
Mar 2024
321.34M
Maximum
Mar 2021
88.22M
Average
48.36M
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly and Co | 51.05B |
| Recursion Pharmaceuticals Inc | 156.70M |
| Creative Medical Technology Holdings Inc | 0.391M |
| CytomX Therapeutics Inc | 216.37M |
| HOOKIPA Pharma Inc | 41.35M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 274.90M |
| Shareholders Equity (Quarterly) | 240.11M |
| Debt to Equity Ratio | 0.0293 |
| Current Ratio | 7.189 |
| Net Debt Paydown Yield | 0.12% |